Taken together, these results validate the association between DSCAM-AS1 and miR-130a to maintain ESR1 levels in PR-positive breast cancer cells with a consistent inverse correlation of miR-130a with the expression of DSCAM-AS1 and ESR1 in the TCGA patient samples. The gene discussed is ESR1; the disease is breast carcinoma.